Zhao Y - Search Results

1

Multistage Delivery Nanoparticle Facilitates Efficient CRISPR/dCas9 Activation and Tumor Growth Suppression In Vivo.

Liu Q, Zhao K, Wang C, Zhang Z, Zheng C, Zhao Y, Zheng Y, Liu C, An Y, Shi L, Kang C, Liu Y. Liu Q, et al. Among authors: zhao k, zhao y. Adv Sci (Weinh). 2018 Oct 25;6(1):1801423. doi: 10.1002/advs.201801423. eCollection 2019 Jan 9. Adv Sci (Weinh). 2018. PMID: 30643726 Free PMC article.

2

In Situ Modification of the Tumor Cell Surface with Immunomodulating Nanoparticles for Effective Suppression of Tumor Growth in Mice.

Zheng C, Wang Q, Wang Y, Zhao X, Gao K, Liu Q, Zhao Y, Zhang Z, Zheng Y, Cao J, Chen H, Shi L, Kang C, Liu Y, Lu Y. Zheng C, et al. Among authors: zhao x, zhao y. Adv Mater. 2019 Aug;31(32):e1902542. doi: 10.1002/adma.201902542. Epub 2019 Jun 11. Adv Mater. 2019. PMID: 31183900

3

NanoRNP Overcomes Tumor Heterogeneity in Cancer Treatment.

Liu Q, Cai J, Zheng Y, Tan Y, Wang Y, Zhang Z, Zheng C, Zhao Y, Liu C, An Y, Jiang C, Shi L, Kang C, Liu Y. Liu Q, et al. Among authors: zhao y. Nano Lett. 2019 Nov 13;19(11):7662-7672. doi: 10.1021/acs.nanolett.9b02501. Epub 2019 Oct 11. Nano Lett. 2019. PMID: 31593471

4

Dual-Locking Nanoparticles Disrupt the PD-1/PD-L1 Pathway for Efficient Cancer Immunotherapy.

Zhang Z, Wang Q, Liu Q, Zheng Y, Zheng C, Yi K, Zhao Y, Gu Y, Wang Y, Wang C, Zhao X, Shi L, Kang C, Liu Y. Zhang Z, et al. Among authors: zhao x, zhao y. Adv Mater. 2019 Dec;31(51):e1905751. doi: 10.1002/adma.201905751. Epub 2019 Nov 11. Adv Mater. 2019. PMID: 31709671

5

Virus-like nanoparticle as a co-delivery system to enhance efficacy of CRISPR/Cas9-based cancer immunotherapy.

Liu Q, Wang C, Zheng Y, Zhao Y, Wang Y, Hao J, Zhao X, Yi K, Shi L, Kang C, Liu Y. Liu Q, et al. Among authors: zhao x, zhao y. Biomaterials. 2020 Nov;258:120275. doi: 10.1016/j.biomaterials.2020.120275. Epub 2020 Aug 7. Biomaterials. 2020. PMID: 32798741

6

Calixarene-Embedded Nanoparticles for Interference-Free Gene-Drug Combination Cancer Therapy.

Liu Q, Zhang TX, Zheng Y, Wang C, Kang Z, Zhao Y, Chai J, Li HB, Guo DS, Liu Y, Shi L. Liu Q, et al. Among authors: zhao y. Small. 2021 Feb;17(8):e2006223. doi: 10.1002/smll.202006223. Epub 2021 Feb 1. Small. 2021. PMID: 33522123

7

Macrocyclic-Amphiphile-Based Self-Assembled Nanoparticles for Ratiometric Delivery of Therapeutic Combinations to Tumors.

Zhang Z, Yue YX, Xu L, Wang Y, Geng WC, Li JJ, Kong XL, Zhao X, Zheng Y, Zhao Y, Shi L, Guo DS, Liu Y. Zhang Z, et al. Among authors: zhao x, zhao y. Adv Mater. 2021 Mar;33(12):e2007719. doi: 10.1002/adma.202007719. Epub 2021 Feb 18. Adv Mater. 2021. PMID: 33598992

8

An Antibody-like Polymeric Nanoparticle Removes Intratumoral Galectin-1 to Enhance Antitumor T-Cell Responses in Cancer Immunotherapy.

Gu Y, Zhao Y, Zhang Z, Hao J, Zheng Y, Liu Q, Liu Y, Shi L. Gu Y, et al. Among authors: zhao y. ACS Appl Mater Interfaces. 2021 May 19;13(19):22159-22168. doi: 10.1021/acsami.1c02116. Epub 2021 May 6. ACS Appl Mater Interfaces. 2021. PMID: 33955217

9

Nanocomposites Inhibit the Formation, Mitigate the Neurotoxicity, and Facilitate the Removal of β-Amyloid Aggregates in Alzheimer's Disease Mice.

Zhao Y, Cai J, Liu Z, Li Y, Zheng C, Zheng Y, Chen Q, Chen H, Ma F, An Y, Xiao L, Jiang C, Shi L, Kang C, Liu Y. Zhao Y, et al. Nano Lett. 2019 Feb 13;19(2):674-683. doi: 10.1021/acs.nanolett.8b03644. Epub 2018 Nov 20. Nano Lett. 2019. PMID: 30444372

10

Stapled Liposomes Enhance Cross-Priming of Radio-Immunotherapy.

Zhao Y, Hou X, Chai J, Zhang Z, Xue X, Huang F, Liu J, Shi L, Liu Y. Zhao Y, et al. Adv Mater. 2022 Jan;34(3):e2107161. doi: 10.1002/adma.202107161. Epub 2021 Nov 21. Adv Mater. 2022. PMID: 34767279

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86,320 results

Search Page

Filters